HeLa (cervical carcinoma) used in this study was a clone expressing the tTA tetracycline transactivator (64 (link)). H1299 cells were obtained from American Type Culture Collection. Cell lines AIDCDK1KO (26 (link)) and AIDCDK2KO (25 (link)) were generated as previously described. mAIDCyclin B1KO was a HeLa cell line expressing cyclin B1-mAID without endogenous cyclin B1 (Adrijana Crncec and RYCP, manuscript in preparation).
AIDCyclin AKO cells from HeLa were generated by retroviral infection (25 (link)) using the construct AID-cyclin A in pRevTRE-AID/Hyg, followed by transfection of cyclin A CRISPR-Cas9 in pX330. AIDCyclin AKO cells from H1299 were generated by transfecting H1299 cells with AID-cyclin A in pUHD-SB-AID/Hyg, pSBbi-TIR1-tTA/Pur (26 (link)), cyclin A CRISPR-Cas9 in pX330, and Sleeping Beauty transposase (pCMV(CAT)T7-SB100; a gift from Zsuzsanna Izsvak; Addgene, #34879) before selecting with hygromycin and puromycin for 2 weeks. AIDCyclin AKO cells lacking CDK2 were generated by cotransfecting CDK2 CRISPR-Cas9 in pX330 and a plasmid expressing blasticidin-resistant gene (a gift from Tim Hunt, Cancer Research UK) into AIDCyclin AKO HeLa cells. After enriching the transfected cells with blasticidin selection for 36 h, the cells were recovered in blasticidin-free medium for 48 h. In all the above cell lines, single cell-derived colonies were obtained by limiting dilution in 96-well plates.
Free full text: Click here